Skip to main content
. 2021 Oct 21;2021:8851354. doi: 10.1155/2021/8851354

Table 4.

Chosen treatment options with and without the use of PERSARC.

Without PERSARC, N (%) With PERSARC, N (%)
Neoadjuvant radiotherapy
 Surgery R0 10 (27.7%) 25 (69.4%)
 Surgery R1 13 (36.1%) 6 (16.7%)
 Surgery R2 2 (5.6%) 0 (0.0%)

Surgery
 Amputation 5 (13.8%) 1 (2.8%)
 R0 2 (5.6%) 1 (2.8%)
 R1 1 (2.8%) 3 (8.3%)
 R2 2 (5.6%) 0 (0.0%)

Adjuvant radiotherapy
 Surgery R0 0 (0.0%) 0 (0.0%)
 Surgery R1 1 (2.8%) 0 (0.0%)
 Surgery R2 0 (0.0%) 0 (0.0%)